Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice

Development

Volumn 131, Issue 8, 2004, Pages 1859-1868

  Mok, Henry ^a   Jelinek, Jaroslav ^a,c   Pai, Sonia ^a   Cattanach, Bruce M ^b   Prchal, Josef T ^a   Youssoufian, Hagop ^a,d   Schumacher, Armin ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MRC MAMMALIAN GENETICS UNIT   (United Kingdom)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d SANOFI   (France)

Author keywords

Ferroportin 1; Hepcidin; Iron homeostasis

Indexed keywords

ERYTHROPOIETIN; FERROPORTIN 1; HEPCIDIN; IRON;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; DUODENUM; ERYTHROPOIESIS; GENE DELETION; GENE MUTATION; HETEROZYGOTE; HOMEOSTASIS; HOMOZYGOTE; HORMONAL REGULATION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; IRON RESPONSIVE ELEMENT; IRON TRANSPORT; LIVER LEVEL; MOLECULAR CLONING; MOUSE; MOUSE MUTANT; NONHUMAN; POLYCYTHEMIA; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROMOTER REGION; RADIATION; REGULATORY MECHANISM; RETICULOENDOTHELIAL SYSTEM; TRANSCRIPTION INITIATION SITE; UPREGULATION;

AGING; ANIMALS; CATION TRANSPORT PROTEINS; ERYTHROPOIESIS; HEMATOCRIT; HOMEOSTASIS; IRON; LIVER; MICE; POLYCYTHEMIA; PROMOTER REGIONS (GENETICS); SEQUENCE DELETION;

ANIMALIA;

EID: 2342440466     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.01081     Document Type: Article

References (57)

1. Abboud, S. and Haile, D. J. (2000). A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275, 19906-19912.
2. Ahmad, K. A., Ahmann, J. R., Migas, M. C., Waheed, A., Britton, R. S., Bacon, B. R., Sly, W. S. and Fleming, R. E. (2002). Decreased liver hepcidin expression in the hfe knockout mouse. Blood Cells Mol. Dis. 29, 361-366.
3. Ajioka, R. S. and Kushner, J. P. (2002). Hereditary hemochromatosis. Semin. Hematol. 39, 235-241.
4. Aisen, P., Enns, C. and Wessling-Resnick, M. (2001). Chemistry and biology of eukaryotic iron metabolism. Int. J. Biochem. Cell. Biol. 33, 940-959.
5. Andrews, N. C. (1999). The iron transporter DMT1. Int. J. Biochem. Cell Biol. 31, 991-994.
6. Arden, K. E., Wallace, D. F., Dixon, J. L., Summerville, L., Searle, J. W., Anderson, G. J., Ramm, G. A., Powell, L. W. and Subramaniam, V. N. (2003). A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut 52, 1215-1217.
7. Aslan, D. and Altay, C. (2003). Incidence of high erythrocyte count in infants and young children with iron deficiency anemia: re-evaluation of an old parameter. J. Pediatr. Hematol. Oncol. 25, 303-306.
8. Bannerman, R. M., Bannerman, C. E. and Kingston, P. J. (1973). Hereditary iron deficiency: X-linked anaemia (sla) in newborn and suckling mice. Br. J. Haematol. 25, 280.
9. Bechensteen, A. G. and Halvorsen, S. (1996). Parenteral iron increases serum erythropoietin concentration during the 'early anaemia' of 10-20-day-old mice. Br. J. Haematol. 94, 529-532.
10. Bernstein, S. E. (1987). Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J. Lab. Clin. Med. 110, 690-705.
11. Bondurant, M. C. and Koury, M. J. (1986). Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol. Cell. Biol. 6, 2731-2733.
12. Cattanach, B. M. (1995). A dominant polycythaemia. Mouse Genome 93, 1027-1028.
13. Cazzola, M., Cremonesi, L., Papaioannou, M., Soriani, N., Kioumi, A., Charalambidou, A., Paroni, R., Romtsou, K., Levi, S., Ferrari, M. et al. (2002). Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3). Br. J. Haematol. 119, 539-546.
14. Chen, H., Su, T., Attieh, Z. K., Fox, T. C., McKie, A. T., Anderson, G. J. and Vulpe, C. D. (2003). Systemic regulation of Hephaestin and Ireg1 revealed in studies of genetic and nutritional iron deficiency. Blood 102, 1893-1899.
15. Devalia, V., Carter, K., Walker, A. P., Perkins, S. J., Worwood, M., May, A. and Dooley, J. S. (2002). Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 100, 695-697.
16. Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A et al. (2000). Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781.
17. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rouke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A. et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
18. Finch, C. (1994). Regulators of iron balance in humans. Blood 84, 1697-1702.
19. Fleming, R. E. and Sly, W. S. (2001). Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding. J. Clin. Invest. 108, 521-522.
20. Ganz, T. (2003). Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102, 783-788.
21. Girelli, D., Corrocher, R., Bisceglia, L., Olivieri, O., de Franceschi, L., Zelante, L. and Gasparini, P. (1995). Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the 'Verona mutation'). Blood 86. 4050-4053.
22. Girelli, D., Corrocher, R., Biseeglia, L., Olivieri, O., Zelante, L., Panozzo, G. and Gasparini, P. (1997). Hereditary hyperferritinemia-cataract syndrome caused by a 29-base pair deletion in the iron responsive element of ferritin L-subunit gene. Blood 90, 2084-2088.
23. Grosovsky, A. J., de Boer, J. G., de Jong, P. J., Drobetsky, E. A. and Glickman, B. W. (1988). Base Substitutions, frameshifts, and small deletions constitute ionizing radiation-induced point mutations in mammalian cells. Proc. Natl. Acad. Sci. USA 226, 245-252.
24. Hellman, N. E. and Gitlin, J. D. (2002). Ceruloplasmin metabolism and function. Annu. Rev. Nutr. 22, 439-458.
25. Hentze, M. W. and Kuhn, L. C. (1996). Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. USA 93, 8175-8182.
26. Hentze, M. W., Caughman, S. W., Rouault, T. A., Barriocanal, J. G., Dancis, A., Harford, J. B. and Klausner, R. D. (1987). Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science 238, 1570-1573.
27. Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S. and Kaelin, W. G., Jr (2001). HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464-468.
28. Jaakkola, P., Mole, D. R., Tian, Y. M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J. et al. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468-472.
29. Jouanolle, A. M., Douabin-Gicquel, V., Halimi, C., Loreal, O., Fergelot, P., Delacour, T., de Lajarte-Thirouard, A. S., Turlin, B., le Gall, J. Y., Cadet, E. et al. (2003). Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload. J. Hepatol. 39, 286-289.
30. Jurado, R. L. (1997). Iron, infections, and anemia of inflammation. Clin. Infect. Dis. 25, 888-895.
31. Kina, T., Ikuta, K., Takayama, E., Wada, K., Majumdar, A. S., Weissman, I. L. and Katsura, Y. (2000). The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br. J. Haematol. 109, 280-287.
32. Knutson, M. and Wessling-Resnick, M. (2003). Iron metabolism in the reticuloendothelial system. Crit. Rev. Biochem. Mol. Biol. 38, 61-88.
33. Lebeau, A., Frank, J., Biesalski, H. K., Weiss, G., Srai, S. K., Simpson, R. J., McKie, A. T., Bahram, S., Gilfillan, S. and Schumann, K. (2002). Long-term sequelae of HFE deletion in C57BL/6 × 129/O1 a mice, an animal model for hereditary haemochromatosis. Eur. J. Clin. Invest. 32, 603-612.
34. Liu, X., Hill, P. and Haile, D. J. (2002). Role of the ferroportin iron-responsive element in iron and nitric oxide dependent gene regulation. Blood Cells Mol. Dis. 29, 315-326.
35. Means, R. T., Jr (2003). Recent developments in the anemia of chronic disease. Curr. Hematol. Rep. 2, 116-121.
36. McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzameh, F. et al. (2000). A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell. 5, 299-309.
37. Miles, C. and Meuth, M. (1989). DNA sequence determination of gamma-radiation-induced mutations of the hamster aprt locus. Mutat. Res. 227, 97-102.
38. Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., Trenor, C. C., Gasparini, P., Andrews, N. C. and Pietrangelo, A. (2001). Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 108, 619-623.
39. Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A. and Vaulont, S. (2001). Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98, 8780-8785.
40. Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A. and Vaulont, S. (2002a). Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. USA 99, 4596-4601.
41. Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A. and Vaulont, S. (2002b). The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037-1044.
42. Nicolas, G., Viatte, L., Bennoun, M., Beaumont, C., Kahn, A. and Vaulont, S. (2002c). Hepcidin, a new iron regulatory peptide. Blood Cells Mol. Dis. 29, 327-335.
43. Nicolas, G., Viatte, L., Lou, D. Q., Bennoun, M., Beaumont, C., Kahn, A., Andrews, N. C. and Vaulont, S. (2003). Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat. Genet. 34, 97-101.
44. Njajou, O. T., Vaessen, N., Joosse, M., Berghuis, B., van Dongen, J. W., Breuning, M. H., Snijders, P. J., Rutten, W. P., Sandkuijl, L. A., Oostra, B. A. et al. (2001). A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat. Genet. 28, 213-214.
45. Park, C. H., Valore, E. V., Waring, A. J. and Ganz, T. (2001). Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276, 7806-7810.
46. Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P. and Loreal, O. (2001). A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chein. 276, 7811-7819.
47. Prchal, J. T. (2001). Molecular biology of polycythemias. Intern. Med. 40, 681-687.
48. Richardson, D. R. and Ponka, P. (1997). The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta. 1331, 1-40.
49. Rivard, S. R., Lanzara, C., Grimard, D., Carella, M., Simard, H., Ficarella, R., Simard, R., D'Adamo, A. P., de Braekeleer, M. and Gasparini, P. (2003). Autosomal dominant reticuloendothelial iron overload (HFE type 4) due to a new missense mutation in the FERROPORTIN 1 gene (SLC11A3) in a large French-Canadian family. Haematologica. 88, 824-826.
50. Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D. and Camaschella, C. (2003). Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33, 21-22.
51. Roy, C. N. and Enns, C. A. (2000). Iron homeostasis: new tales, from the crypt. Blood 96, 4020-4027.
52. Semenza, G. L. (1998). Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J. Lab. Clin. Med. 131, 207-214.
53. Torrance, J. D. and Bothwell, T. H. (1980). In Iron (ed. J. D. Cook), pp. 32-35, 90-115. New York: Churchill Livingstone.
54. Vulpe, C. D., Kuo, Y. M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., Gitschier, J. and Anderson, G. J. (1999). Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21, 195-199.
55. Yang, F., Liu, X. B., Quinones, M., Melby, P. C., Ghio, A. and Haile, D. J. (2002). Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J. Biol. Chem. 277, 39786-39791.
56. Zhang, J., Socolovsky, M., Gross, A. W. and Lodish, H. F. (2003). Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 102, 3938-3946.
57. Zoller, H., Theurl, I., Koch, R., Kaser, A. and Weiss, G. (2002). Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1. Blood Cells Mol. Dis. 29, 488-497.